Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 81 citations in OpenAlex.

1. Progestogens for maintenance tocolysis in symptomatic women. A systematic review and meta-analysis.PloS one · 2023
   Pooled it
2. 17-Hydroxyprogesterone caproate in triplet pregnancy: an individual patient data meta-analysis.BJOG : an international journal of obstetrics and gynaecology · 2016
   Pooled it
3. Pharmacokinetics of vaginal progesterone in pregnancy.American journal of obstetrics and gynecology · 2019
   Trial
4. Challenges in Using Progestin to Prevent Singleton Preterm Births: Current Knowledge and Clinical Advice.International journal of women's health · 2024
   Review
5. The end is where we start from: withdrawal of 17-alpha hydroxyprogesterone caproate to prevent recurrent preterm birth.American journal of obstetrics and gynecology · 2024
   Article
6. Addressing a broken drug pipeline for preterm birth: why early preterm birth is an orphan disease.American journal of obstetrics and gynecology · 2023
   Article
7. What now? A critical evaluation of over 20 years of clinical and research experience with 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention.American journal of obstetrics & gynecology MFM · 2023
   Review
8. Advances and challenges in studying the tissue-resident T cell compartment in the human female reproductive tract.Immunological reviews · 2023
   Review
9. Maternal-fetal conflict averted by progesterone- induced FOXP3+ regulatory T cells.iScience · 2022
   Article
10. Progesterone Receptor Signaling in the Uterus Is Essential for Pregnancy Success.Cells · 2022
    Review
11. In utero exposure to 17α-hydroxyprogesterone caproate and risk of cancer in offspring.American journal of obstetrics and gynecology · 2022
    Article
12. Vaginal progesterone for prevention of preterm birth in asymptomatic high-risk women with a normal cervical length: a systematic review and meta-analysis protocol.Systematic reviews · 2021
    Article
13. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence.American journal of obstetrics and gynecology · 2020
    Review
14. Developmental exposure to 17α-hydroxyprogesterone caproate impairs adult delayed reinforcement and reversal learning in male and female rats.Journal of neuroendocrinology · 2020
    Article
15. Controversies about the Secondary Prevention of Spontaneous Preterm Birth.Geburtshilfe und Frauenheilkunde · 2018
    Article
16. Mid-Luteal 17-OH Progesterone Levels in 614 Women Undergoing IVF-Treatment and Fresh Embryo Transfer-Daytime Variation and Impact on Live Birth Rates.Frontiers in endocrinology · 2018
    Article
17. Evaluating progestogens for prevention of preterm birth international collaborative (EPPPIC) individual participant data (IPD) meta-analysis: protocol.Systematic reviews · 2017
    Article
18. 17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study.American journal of obstetrics and gynecology · 2017
    Article
19. Recent advances in the prevention of preterm birth.F1000Research · 2017
    Review
20. Recurrent pregnancy loss: current perspectives.International journal of women's health · 2017
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 2 institutions in 1 country.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as